SIMON PEDDER
Profile
First Name
: SIMON
Middle Name
:
Last Name
: PEDDER
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
CHARLES T. BERNHARDT, PAUL BERNS, JAMES V. CARUSO, ASHER ALBAN CHANAN-KAHN, MICHAEL J. DOYLE, FREDERICK W DRISCOLL, FREDERICK W. DRISCOLL, DOV ELEFANT, SIMM FASS, JOHN FRIEND, JOHN E. FRIEND II, JOHN P. HAMILL, KIM HAWKINS, STEPHEN A. HILL, CHAD J. KOLEAN, DARRELL SHANE LEA, JARROD LONGCOR, STEFAN LOREN, STEFAN D. LOREN, THOMAS ROCKWELL MACKIE, JAMES S. MANUSO, DAVID B. MCWILLIAMS, JOHN E. NEIDERHUBER, JOHN NEIS, ELIAS NYBERG, HARRY S. PALMIN, CHRISTOPHER J. PAZOLES, JOANNE M. PROTANO, HOWARD M. SCHNEIDER, KRISTIN C. SCHUHWERK, ANDREI SHUSTOV, DOUGLAS J. SWIRSKY, MICHAEL F. TWEEDLE, JAMEY P. WEICHERT
EXECUTIVE OFFICER
ALLEN BARNETT, FLINT BESECKER, KIM CAMPBELL, STEPHANIE DAVIS, LYN DYSTER, MANSON FOK, DAVID HANGAUER, DAVID HSIA, JAMES HUSSEY, JORDAN KANFER, JOHN KOH, RUDOLF KWAN, RUDOLPH KWAN, CHARLES LANNON, JOHNSON LAU, ANTONY LEUNG, MICHAEL MURPHY, NICK RIEHLE, LI SHEN, JEAN-PIERRE SOMMADOSSI, RANDOLL SZE, SHELDON TRAINOR-DEGIROLAMO, BENSON TSANG, BENSON KWAN HUNG TSANG, JOHN VIERLING, JINN WU, JEFFREY YORDON, SONG-YI ZHANG, SONGYI ZHANG, WILLIAM ZUO, WILLIAM KWAN HUNG ZUO
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-12-22
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-12-22
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-12-22
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-12-22
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-12-09
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$25,000,001 - $100,000,000
Equity
2019-05-03
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-06-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2017-04-19
